Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exosomes and Resistance to Immunotherapy in Aggressive Non-Hodgkin B-cell Lymphomas (B-NHL)

NCT03985696 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.

NCT NCT03985696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03985696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exosomes and Resistance to Immunotherapy in Aggressive Non-Hodgkin B-cell Lymphomas (B-NHL)
Lead sponsor
University Hospital, Limoges
Phase
Not applicable
Overall status
Completed
Start date
July 2, 2019
Completion date
July 2, 2025
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, b-cell, aggressive non-hodgkin (b-nhl)